Wockhardt surged 17% to a 52-week high of Rs 1,809.
Filed for DCGI approval for Zaynich; India launch expected in H2 FY25-26.
Q4 loss narrowed to Rs 45 crore; EBITDA up 13% QoQ.
Strong growth in UK and Ireland businesses; multiple new product filings.
Comments
Post a Comment